Akiyo Taneichi

Shimotsuke, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Progesterone Is Associated With Increased Vasohibin-2 Expression, Tubulin Detyrosination, and Paclitaxel Sensitivity in PR-Negative Ovarian Cancer Cells.

Progesterone Is Associated With Increased Vasohibin-2 Expression, Tubulin Detyrosination, and Paclitaxel Sensitivity in PR-Negative Ovarian Cancer Cells.

Journal: Cancer reports (Hoboken, N.J.)

Published: March 21, 2026

Recovery from severe adriamycin-induced cardiomyopathy after prolonged intensive care in a patient with uterine leiomyosarcoma: A case report.

Recovery from severe adriamycin-induced cardiomyopathy after prolonged intensive care in a patient with uterine leiomyosarcoma: A case report.

Journal: Experimental and therapeutic medicine

Published: February 21, 2026

Progesterone Enhances the Sensitivity of Ovarian Cancer Cells to Poly (ADP-Ribose) Polymerase (PARP) Inhibitors by Suggesting a Role for Transcription-Replication Conflict-Related Pathways: An In Vitro Study.

Progesterone Enhances the Sensitivity of Ovarian Cancer Cells to Poly (ADP-Ribose) Polymerase (PARP) Inhibitors by Suggesting a Role for Transcription-Replication Conflict-Related Pathways: An In Vitro Study.

Journal: Cureus

Published: January 17, 2026

Acute myocardial infarction caused by coronary tumor embolism from uterine leiomyosarcoma: a case report.

Acute myocardial infarction caused by coronary tumor embolism from uterine leiomyosarcoma: a case report.

Journal: Gynecologic oncology reports

Published: January 14, 2026

Severe Lymphorrhea Mimicking Hypovolemic Shock Following Retroperitoneal Lymphadenectomy for Endometrial Cancer: A Case Report.

Severe Lymphorrhea Mimicking Hypovolemic Shock Following Retroperitoneal Lymphadenectomy for Endometrial Cancer: A Case Report.

Journal: The journal of obstetrics and gynaecology research

Published: December 08, 2025

Efficacy of lenvatinib plus pembrolizumab for recurrent endometrial cancer: a focus on the nonendometrioid histology including carcinosarcoma.

Efficacy of lenvatinib plus pembrolizumab for recurrent endometrial cancer: a focus on the nonendometrioid histology including carcinosarcoma.

Journal: Japanese journal of clinical oncology

Published: November 17, 2025

Disseminated peritoneal leiomyomatosis incidentally diagnosed during surgery for torsion of a subserosal uterine fibroid: a case report.

Disseminated peritoneal leiomyomatosis incidentally diagnosed during surgery for torsion of a subserosal uterine fibroid: a case report.

Journal: Journal of medical case reports

Published: March 06, 2025

Progesterone Enhances Sensitivity of Ovarian Cancer Cells to SN38 Through Inhibition of Topoisomerase I and Inducing Ferroptosis.

Progesterone Enhances Sensitivity of Ovarian Cancer Cells to SN38 Through Inhibition of Topoisomerase I and Inducing Ferroptosis.

Journal: Cancer reports (Hoboken, N.J.)

Published: January 20, 2025

Effectiveness of cervical cancer screening with cytology and human papillomavirus co-testing: A 12-year retrospective study in Oyama district, Japan.

Effectiveness of cervical cancer screening with cytology and human papillomavirus co-testing: A 12-year retrospective study in Oyama district, Japan.

Journal: Cancer epidemiology

Published: November 16, 2024

Forced Vasohibin-1 Expression Increases Paclitaxel Sensitivity of Ovarian Cancer by Inhibiting Microtubule Activity.

Forced Vasohibin-1 Expression Increases Paclitaxel Sensitivity of Ovarian Cancer by Inhibiting Microtubule Activity.

Journal: Cancer reports (Hoboken, N.J.)

Published: March 27, 2024

Increase in creatinine levels associated with niraparib maintenance therapy in ovarian cancer.

Increase in creatinine levels associated with niraparib maintenance therapy in ovarian cancer.

Journal: The journal of obstetrics and gynaecology research

Published: June 26, 2023

The role of non-genomic actions of progesterone and its membrane receptor agonist in ovarian cancer cell death.

The role of non-genomic actions of progesterone and its membrane receptor agonist in ovarian cancer cell death.

Journal: Cancer reports (Hoboken, N.J.)

Published: June 25, 2023

Showing 1-12 of 37

Last Updated: 09/26/2026